Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Aligos Therapeutics, Inc. (ALGS) is the issuer whose shares are reported as beneficially owned by Parkman Healthcare Partners LLC, Parkman Healthcare Partners Holdings LP, Parkman Healthcare Partners Holdings GP LLC, and Gregory Martinez, identified as a managing member. Each reports the same 325,537 shares, or 5.2%, with shared voting and dispositive power, as of September 30, 2026.
The shares are directly owned by advisory clients of Parkman Healthcare Partners LLC; the report says none of those clients may be deemed to beneficially own more than 5% of the common stock. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interests.
Key Figures
Shares beneficially owned:325,537 sharesPercent of class:5.2%
2 metrics
Shares beneficially owned325,537 sharesEach of the four reporting persons reported this amount as of September 30, 2026.
Percent of class5.2%Reported by each reporting person as of September 30, 2026.
"disclaims beneficial ownership of the reported securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Powerregulatory
"Shared Voting Power 325,537.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 325,537.00"
pecuniary interestfinancial
"except to the extent of his, her or its pecuniary interest therein"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ALGS shares did the Parkman reporting persons report?
Each of the four reporting persons reported 325,537 shares, or 5.2%, with shared voting and dispositive power as of September 30, 2026.
Parkman Healthcare Partners LLC - Delaware
Parkman Healthcare Partners Holdings LP - Delaware
Parkman Healthcare Partners Holdings GP LLC - Delaware
Gregory Martinez - United States
(d)
Title of class of securities:
Common Stock par value, $0.0001 per share
(e)
CUSIP Number(s):
01626L204
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G are directly owned by advisory clients of Parkman Healthcare Partners LLC. None of those advisory clients may be deemed to beneficially own more than 5% of the Common Stock par value, $0.0001 per share.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Parkman Healthcare Partners LLC is the relevant entity for which Parkman Healthcare Partners Holdings LP, Parkman Healthcare Partners Holdings GP LLC, and Gregory Martinez may be considered control persons.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Parkman Healthcare Partners LLC
Signature:
/s/ Gregory Martinez
Name/Title:
Gregory Martinez, Managing Member
Date:
11/13/2026
Parkman Healthcare Partners Holdings LP
Signature:
/s/ Gregory Martinez
Name/Title:
Gregory Martinez, Managing Member
Date:
11/13/2026
Parkman Healthcare Partners Holdings GP LLC
Signature:
/s/ Gregory Martinez
Name/Title:
Gregory Martinez, Managing Member
Date:
11/13/2026
Gregory Martinez
Signature:
/s/ Gregory Martinez
Name/Title:
Gregory Martinez
Date:
11/13/2026
Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
